-
Cancer Drug Responses: Growth Inhibition vs Cell Death
2026-09-30
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measurements capture different components of an anticancer response. The work provides a stronger framework for interpreting drug effects by considering both the magnitude and timing of proliferative arrest and cell killing.
-
Amplex Red for Reliable H2O2 Assays
2026-09-30
This scenario-based guide explains how Amplex Red (SKU C4839) can strengthen hydrogen peroxide detection, oxidative stress monitoring, and redox assay workflows without being mistaken for a direct viability readout. It covers assay design, controls, protocol optimization, interpretation, and practical supplier selection for biomedical laboratories.
-
Arsenic, MMP-2/MMP-9, and Cognitive Impairment
2026-09-29
The reference study links chronic sodium arsenite exposure to cognitive impairment through MMP-2/MMP-9-associated blood-brain barrier disruption, tight-junction loss, and hippocampal neuronal apoptosis. Its doxycycline intervention provides pharmacological evidence that preserving barrier integrity may lessen arsenic-related behavioral deficits, while also highlighting important limits on causal and translational interpretation.
-
FK866 (APO866) Applied NAMPT Workflows
2026-09-29
FK866 (APO866) enables controlled interrogation of NAD dependence in hematologic cancer models and exploratory macrophage host-defense assays. This guide connects target engagement, metabolic depletion, mitochondrial injury, and pathogen-centered readouts in one practical workflow.
-
LDH Cytotoxicity Assay Kit: Practical Workflow
2026-09-28
The LDH Cytotoxicity Assay Kit supports endpoint cell cytotoxicity measurement by detecting LDH released into culture medium after loss of membrane integrity. It is suitable for controlled cytotoxicity and cell damage studies, but it should not be used alone to identify the mode of cell death or to provide real-time lysis kinetics.
-
AO/PI Double Staining Kit: Practical Workflow
2026-09-28
The AO/PI Double Staining Kit provides a rapid fluorescent readout to distinguish green AO-stained cells, orange AO-stained cells with condensed chromatin, and PI-positive cells with compromised membrane integrity. Use it for fluorescence-based assessment of cultured cell samples, not as a stand-alone proof of apoptosis mechanism or a substitute for tissue imaging methods.
-
Ionomycin Calcium Salt in Cancer Assay Design
2026-09-27
Ionomycin calcium salt is a calcium ionophore for controlled studies of intracellular Ca2+ and cell fate. This article explains how to use calcium perturbation as a carefully bounded, orthogonal assay variable alongside cancer-response studies—without confusing it with evidence for DNA-repair targeting.
-
Indometacin Sodium: Applied Assay Workflows
2026-09-26
Build more informative inflammation and remyelination experiments with Indometacin Sodium by matching dose, model, and readout to its multiple biological actions. A practical workflow pairs reported concentration ranges with vehicle controls, orthogonal endpoints, and careful interpretation of drug-related phenotypes.
-
FK866 (APO866) Workflows for Cancer Research
2026-09-25
Use FK866 (APO866) to test how NAMPT-dependent NAD depletion affects cancer-cell survival, with practical workflows for dose finding, metabolic readouts, and cell-death profiling. The approach also offers a careful way to investigate NAD-related resistance hypotheses raised by ovarian cancer research—without treating findings from one cancer model as proof in another.
-
Thymoquinone Protects Against Doxorubicin Cardiotoxicity
2026-09-25
A mouse study reports that thymoquinone attenuated doxorubicin-associated cardiac dysfunction and oxidative injury, with findings consistent with reduced ferroptosis and engagement of Nrf2/HO-1 signaling. Its dose groups and cardiac, biochemical, and tissue readouts offer a useful preclinical framework, while the results remain mechanistic evidence from an animal model rather than proof of clinical benefit.
-
GI 254023X: Practical ADAM10 Inhibitor Workflows
2026-09-24
GI 254023X pairs nanomolar ADAM10 potency with selectivity over ADAM17, making it useful for focused studies of protein shedding, Notch1 signaling, and endothelial barrier injury. This guide turns those use-cases into controlled cell-assay workflows, with troubleshooting advice and a clear distinction between established product findings and questions researchers still need to test.
-
ECL Chemiluminescent Substrate Detection Kit
2026-09-24
Learn how to use ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231, to support western blot chemiluminescent detection of low-abundance proteins. This scenario-based guide distinguishes cell phenotype assays from protein detection and covers membrane compatibility, signal timing, and practical product-selection considerations.
-
Thrombin B-Chain Fragment: Identity and Research Use
2026-09-23
Thrombin is a trypsin-like serine protease with central roles in fibrin formation and platelet signaling. A1057 is a sequence-defined 17-residue thrombin B-chain fragment, so it should not be treated as intact, catalytically active thrombin.
-
MALAT1–miR-125b–STAT3 Axis in Sepsis PCT
2026-09-23
The reference study identifies a MALAT1–miR-125b–STAT3 regulatory circuit that increases procalcitonin expression in sepsis-related inflammatory models. Its combination of clinical samples, U937-cell experiments, fluorescence in situ hybridization, RNA interaction assays, and rescue experiments provides a mechanistic framework for interpreting PCT regulation, while leaving clinical validation and causal translation as important next steps.
-
Aβ42: From Ion Channels to AD Translation
2026-09-22
A mechanistic and translational guide to using Amyloid β-Peptide (1-42) in Alzheimer’s disease research, connecting aggregation state, neuronal ion channel modulation, neurotoxicity assays, and evidence from olive biophenol studies.